DTIL
Precision BioSciences, Inc.
NASDAQ · Healthcare · Biotechnology · US
$7.47
+1.36%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- 29.04x
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 4.55x
- Price / sales
- 4.58x
- Price / cash flow
- -3.97x
Enterprise value
- Enterprise value
- $146.7M
- EV / sales
- 3.26x
- EV / EBITDA
- -2.93x
- EV / EBIT
- -4.03x
- Market cap
- $206.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Jun 1, 2026